INBX Competitors & Alternatives
Compare Inhibrx Biosciences, Inc. with similar stocks in the same industry
Biotechnology
INBX
Main Stock$97.58
Tradestie Score
52
Market Cap
$492.21M
Revenue Growth
-1.0%
Analyst Upside
+184.4%
Top Competitors
233 stocks in Biotechnology| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
AUPH
Aurinia Pharmaceuticals Inc
|
$15.61
|
$1.50B | 7.3 | 55 | Compare |
|
GPCR
Structure Therapeutics Inc. American Depositary Shares
|
$53.45
|
$1.50B | - | 57 | Compare |
|
AMLX
Amylyx Pharmaceuticals, Inc. Common Stock
|
$18.27
|
$1.49B | - | 59 | Compare |
|
RCUS
Arcus Biosciences, Inc.
|
$30.33
|
$1.43B | - | 60 | Compare |
|
JANX
Janux Therapeutics, Inc. Common Stock
|
$15.54
|
$1.42B | - | 60 | Compare |
|
SNDX
Syndax Pharmaceuticals, Inc.
|
$21.82
|
$1.35B | - | 57 | Compare |
|
RAPP
Rapport Therapeutics, Inc. Common Stock
|
$38.97
|
$1.32B | - | 61 | Compare |
|
XERS
Xeris Biopharma Holdings, Inc. Common Stock
|
$8.28
|
$1.29B | 114.3 | 58 | Compare |
|
STOK
Stoke Therapeutics, Inc. Common Stock
|
$32.70
|
$1.29B | - | 61 | Compare |
|
ARDX
Ardelyx, Inc.
|
$5.27
|
$1.29B | - | 49 | Compare |
More INBX Analysis
Data updated: Jul 04, 2026 | Industry: Biotechnology (SIC 2836)
233 stocks in this industry